INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,240 | -22.5% | 2,000 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $81,560 | +9.4% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $74,540 | +6.8% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $69,780 | -37.7% | 2,000 | 0.0% | 0.01% | -36.4% |
| Q3 2022 | $112,000 | +7.7% | 2,000 | 0.0% | 0.01% | +10.0% |
| Q2 2022 | $104,000 | -28.3% | 2,000 | 0.0% | 0.01% | +11.1% |
| Q1 2022 | $145,000 | -38.6% | 2,000 | 0.0% | 0.01% | -40.0% |
| Q4 2021 | $236,000 | -11.9% | 2,000 | 0.0% | 0.02% | -21.1% |
| Q3 2021 | $268,000 | -17.3% | 2,000 | 0.0% | 0.02% | -9.5% |
| Q2 2021 | $324,000 | +101.2% | 2,000 | 0.0% | 0.02% | +90.9% |
| Q1 2021 | $161,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |